Skip to content

Prospective, multicenter, self-controlled clinical trial to evaluate the efficacy and safety of a magnetic capsule endoscopy system for the examination of gastric diseases

Prospective, multicenter, self-controlled clinical trial to evaluate the efficacy and safety of a magnetic capsule endoscopy system for the examination of gastric diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122066
Enrollment
Unknown
Registered
2026-04-08
Start date
2024-03-29
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal disorders

Interventions

Gold Standard:Diagnosis of comparative device
Index test:Diagnosis of test device

Sponsors

Shenzhen Bao'an People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Ages 8 to 70 years old and gender is not limited 2. Those with or without upper gastrointestinal symptoms for whom gastroscopy is proposed 3. Those who are able to understand the purpose of the trial, who voluntarily participate and sign an informed consent form, and who are willing to comply with the requirements of the trial.

Exclusion criteria

Exclusion criteria: 1. Gastrointestinal obstruction, digestive tract malformation, digestive tract perforation, stenosis or fistula, etc. confirmed by examination 2. Those in the acute stage of corrosive esophageal injury 3. All kinds of acute enteritis, severe iron deficiency disease and radiation enteritis, such as active stage of bacillary dysentery, acute stage of ulcerative colitis, diverticulitis, etc 4. Those who have a history of gastrolithiasis and those who have undergone gastrointestinal surgery in the last three months 5. Those with severe dysphagia, or those who cannot insert the gastroscope due to acute severe pharyngeal disorders, etc 6. Those who have pacemakers (except for new MRI-compatible products), defibrillators, electronic cochlear implants, magnetic metal drug infusion pumps, neurostimulators, magnetic metal foreign bodies, and other electronic instruments implanted in the body that are susceptible to magnetic field interference 7. Those who are allergic to anesthesia drugs, or gastric preparation drugs such as defoaming agent simethicone emulsion, streptozotocin granules, pure sodium bicarbonate powder, or polymer materials 8. Pregnant and lactating women 9. Patients with severe heart disease such as severe arrhythmia, active stage of myocardial infarction, severe heart failure, congestive heart failure 10. Patients who cannot lie down due to severe lung diseases such as asthma, respiratory failure, etc 11. Patients with severe renal insufficiency 12. Those who have incurable bleeding factors or are receiving anticoagulation therapy 13. Those who have participated in other interventional clinical trials within one month and have not met the primary endpoints 14. Those with other contraindications to gastroscopy 15. Other conditions that in the judgment of the investigator are not suitable for enrollment

Design outcomes

Primary

MeasureTime frame
Diagnostic concordance rate;

Secondary

MeasureTime frame
Image analysis software function evaluations;Subject discomfort level;Subject discomfort level;negative gastric diagnostic accordance rate;Evaluation of magnet controlled capsule endoscope system;Subjects' gastric preparation quality;Gastroscopy results;Proportion of good quality images;Inspection time;

Countries

China

Contacts

Public ContactFu Ya

Shenzhen Bao'an People's Hospital

fuyaszba@126.com+86 755 2778 8311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026